Sure...if you want to count the raw materials at the plant the LCY may purchase, or the Reverdia Agreement that still hasn’t happened, or perhaps the office equipment in St.Paul...there are many “other” transactions possible.
But none that will involve the shareholders of BIOAQ seeing a cent.
Here is what a lot of folks don’t realize...if there was actually a deal possible that got shareholders a return that was even just equivalent to the current share price...which would have required ALL the creditors to be paid off, in full, standing ahead in line on its claims to assets...
...BioAmber would not have needed to declare bankruptcy to begin with and CERTAINLY NOT have had to go to liquidation.
Market Data 
Markets 
AI
